Director, HEOR
Position Summary:
The Director, HEOR is an integral member of the HEOR team who leverages therapeutic and product knowledge of Novartis oncology product(s) to optimize access and reimbursement for pipeline, newly launched and marketed product(s) in the US. In this role, The Director has overall responsibility for strategically developing health outcomes research and generating data that demonstrates the economic and humanistic value of Novartis oncology product(s). The Director works on cross-functional teams to support Novartis oncology product(s), serving as the value evidence content expert for assigned product(s), with an emphasis on establishing the value evidence strategy for the product(s). Additionally, within the function, this role serves as a resource, to provide guidance, coaching and mentoring to HEOR colleagues.
Job responsibilities will include:
HEOR functional expert on cross functional product strategy teams for assigned pipeline newly launched and/or marketed Novartis product(s) in the US.
Assess research gaps and objectives across key partners and therapeutic area to determine appropriate outcomes research strategy, research objectives and tactical plan.
Establish and manage strategy and execution for Product/Indication HEOR Annual Strategic Plan to conduct timely, high quality and relevant HEOR research.
Develop strategy to support business needs on varying projects requiring HEOR research principles and applications in the US Oncology therapeutic area setting.
Lead HEOR study management including vendor management, contracting and budget
Ensure compliance with all legal/regulatory and Novartis requirements/policies for HEOR (publications and communications, GPP, Pharma codes, NVS SOPs/WPDs/guidance, Sunshine Act/ Clinical Transparency).
Collaborate with cross-functional teams to identify strategies and execute tactics to support the value of Novartis Oncology product(s) (e.g. Integrated Disease Oriented Clinical Strategy Team [iDOCS], launch management teams [LMT], Global Oncology Scientific Affairs).
Manage the strategy for, development of, submissions to, and interactions with payer groups, and regulatory authorities to maximize US patient access and reimbursement for Novartis Oncology product(s).
Develop yearly budget for assigned product (s) and manage monthly spend within allocated budget.
Design Phase IIIB/IV studies with HEOR endpoints to support US region.
Develop, validate and/or use PRO measures including FDA interactions.
Identify the strategy and manage the execution and reporting of US claims database analyses to assess burden and cost of disease for specific indication(s).
Develop model strategy and execute on model development to assess the value of medical
product(s) and predict budget impact.
Presents health outcomes projects and information to internal Novartis groups and supports the
external dissemination of this evidence to payers, clinicians and patient advocacy groups.
Provide value evidence training to multiple internal customers (e.g. sales force, customer
interaction center (CIC), MSLs, clinical) for assigned product(s).
Create and update value messages, burden of disease, unmet need and economic value sections
of AMCP dossier and ensure timely annual updates.
Collaborate compliantly with Global Oncology, US Clinical Development and Medical Affairs (US
CDMA), Marketing / Managed Markets functions, in order to ensure alignment of US Oncology
HEOR strategy with business and customer needs.
Support HEOR VP in developing and implementing operational processes for internal
department as it relates to daily HEOR activities.
Anticipate and lead development of strategies and tactics to support department operational
needs.
Proactively identify opportunities to improve business processes and output.
Participate in multiple projects to ensure HEOR capabilities are utilized, both cross-functionallyPosition Requirements
EDUCATION: Doctoral degree (PhD or PharmD, or MD) in related field
EXPERIENCE:
At least 8 years- experience in outcomes research with a minimum of 3 years of pharmaceutical industry-related health economics and outcomes research.
Demonstrated development and delivery of HEOR communications for external US audiences (e.g., payers, FDA, academic centers or IDN) for multiple product(s)/therapeutic indications.
Demonstrated knowledge of US payer environment and payer/policy maker evidence needs for access and reimbursement.
Design of multiple Phase IIIB/IV studies with HEOR endpoints to support US region. Development, validation and/or use of PRO measures including FDA interactions for multiple therapeutic indications.
Analysis of US claims databases to assess burden and cost of disease in multiple therapeutic indications.
Demonstrated model development to assess the value of medical product(s) and predict budget impact in multiple therapeutic indications.
Solid knowledge of the HEOR field, including key opinion leaders, leading academic researches and consultants.
Strong knowledge base of sources of clinical information including epidemiology of disease
Demonstrated strategic agility to lead the development of innovative solutions to meet the emerging business needs.
Ability to manage multiple projects within defined timelines.
Ability to mentor and act as a resource to junior colleagues.
ref: (253876BR)
